期刊文献+

噻嗪类利尿剂及氯沙坦对原发性高血压的血清尿酸水平的影响

Effect of thiazide diuretics and losartan on serum uric acid in essential hypertension
下载PDF
导出
摘要 目的:观察原发性高血压患者分别服用噻嗪类利尿剂、氯沙坦4周后血清尿酸的变化。方法:对在我院连续诊疗的原发性高血压患者128例随机分为利尿剂组和氯沙坦组,利尿剂组63例,氯沙坦组65例。结果:两组药物均能明显降低患者的血压,且两组降压幅度无明显差异。利尿剂组治疗后尿酸平均升高41.67μmol/L(P<0.01),氯沙坦组平均下降30.47μmol/L(P<0.01),两组药物治疗后尿酸之间的差异有显著性。结论:噻嗪类利尿剂会升高原发性高血压病患者尿酸水平,氯沙坦可降低原发性高血压患者的尿酸水平。 Objective :To survey the serum uric acid changes after 4-week antihypertensive treatment with thiazide diuretics,losartan in the patients with essential hypertension. Methods:A total of 128 consecutive patients with essential hypertension were allocated randoraly to diuretics group (n=63), losartan group (n=65). The blood pressure and serum uric acid,before and after antihypertensive treatments,were obtained in all patients. Results :Two groups,diuretics group and losartan group,could significantly lower blood pressure, and the range of lowering blood pressure had no significant difference. Serum uric acid was significantly increased (41.67 umol/L) in diuretics group(P〈0.01),but significantly reduced (30.47 umol/L) in losartan group(P〈0.01). Conclusion:The thiazide diuretics could further aggravate hyperurieaciduria while losartan could reduce hypemfieaeiduria in the patients with essential hypertension.
机构地区 安康市人民医院
出处 《现代医药卫生》 2009年第12期1771-1772,共2页 Journal of Modern Medicine & Health
关键词 高血压 高尿酸血症 噻嗪类利尿剂 氯沙坦 Hypertension Hyperuricemia Antihypertensive agents
  • 相关文献

参考文献4

  • 1Milionis Hl,Elisaf MS. Management of hypertension and dyslipidaemia in patients presenting with hyperuricemia:case histories[J]. Curr Med Res Opin,2000,16(4) : 164.
  • 2Mercuro G, vitale C, Cerquetani E,et al.Effect of hyperuficemia upon endothelial function in patients at increased cardiovascular rlsk[J]. Am J cardiol, 2004,94(7) :932.
  • 3薛丽,张爱伦.高尿酸血症与心血管疾病研究进展[J].医学综述,2006,12(2):90-91. 被引量:66
  • 4Kaplan NM,Gifford RW Jr.Choice of initial therapy for hypertension[J]. JAMA, 1996,275(20) : 1577.

二级参考文献19

  • 1Chu NF, Wang D J, Liou SH, et al. Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan[ J ]. Eur J Epidemiol, 2000,16( 1 ) : 13-17.
  • 2Corella D, Silla J, Ordovas JM, et al. Association of blood uric acid with other cardiovascular risk factors in the male working population in Valencia[J]. Rev Clin Esp, 1999,199(12) : 806-812.
  • 3Kanishi N, Okamoto M, Yoshida H, et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type Ⅱ diabetes in Japanese male office workers [ J ]. Eur J Epidemiol, 2003, 18(6) :523-530.
  • 4Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES Ⅰ epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey [J]. JAMA, 2000, 283 ( 18 ) : 2404-2410.
  • 5Puddu PE, Lanti M, Menotti A, et al. Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study[J].Acta Cardiol,2001,56(4) :243-251.
  • 6Alderman M, Aiyer KJ. Uric acid:role in cardiovascular disease and effects of losartan[J] .Curr Med Res Opin,2004,20(3) :369-379.
  • 7Freedman DS, Williamson DF, Gentr EW, et al. Relation of serum acid to mortality and iachemic heart disease. The NHANNESI Eoidemiologic Follow-up study[J] .Am J Epidemiol, 1995,141(7) :637-644.
  • 8Nieto FJ, Lribarren C, Gross MD, et al. Uric acid and serum antioxidant capacity, a reaction to atherosclerosis? [ J ]. Atherosclerosis, 2000, 148(1) :131-139.
  • 9Suarna C, Dean RT, May J, et al. Human atherosclerotic plaque contains both oxidizerd lipids and relatively large amounts of alpha-topherol and ascobate[J]. Arterioscler Throlnb Vase Biol, 1995, 15(10) : 1661-1624.
  • 10Anker SD,Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure:validation and application in metabolic, functional, and hemodynamic staging [ J ]. Circulation, 2003, 107 ( 15 ) : 1991-1997.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部